In case anyone needed more evidence supporting Max's statement this sobering comment from the Optician about gene therapy for ocular diseases may be of interest. The article says:
So here we have diseases of the eye, generally regarded as the easiest target for gene therapy, taking two decades to report results. Kinda makes a few weeks delay for TT-034 seem insignificant don't you think?
- Forums
- ASX - By Stock
- time for a reality check
In case anyone needed more evidence supporting Max's statement...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)